Loading clinical trials...
Loading clinical trials...
This is a prospective, open large cohort study to explore biomarkers for detecting early carcinogenesis of IPMN.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Zhejiang University
Collaborators
NCT07216521 · Intraductal Papillary Mucinous Neoplasm
NCT04291651 · Pancreatic Cyst, Pancreatic Neoplasms, and more
NCT06638866 · Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, and more
NCT03729453 · Intraductal Papillary Mucinous Neoplasm
NCT02110498 · Pancreatic Cysts, Intraductal Papillary Mucinous Neoplasm, and more
the First Affiliated Hospital, School of Medicine, Zhejiang University
Hangzhou, Zhejiang
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions